Business

Luxury French Alcohol Brand Cardinal du Four Enters Multi-year Partnership with Los Angeles Rams   Cardinal du Four, 21 Rébellion, the award-winning, additive-free Armagnac and the modern connoisseur’s answer to Cognac, has partnered with the Los Angeles Rams. As part of the partnership, Cardinal du Four will create bespoke marketing and advertising messaging, as well
0 Comments
Today #TheSimonettaLeinShow continues its highly anticipated 6th Season, as the show welcomes New York Times best-selling author, keynote speaker, and industry-leading show host, Lewis Howes! Lewis is a two-sport All-American athlete, former professional football player, and member of the U.S.A. Men’s National Handball Team. His show, “The School of Greatness” is one of the top podcasts in
0 Comments
The SpaceX Starship has launched its second orbital test flight. Which means that America now is about to have two mega-rockets, two of the biggest rockets ever to take to the skies. One is SpaceX’s Starship.  The other is NASA’s Artemis Moon Rocket. How do the two stack up against each other? The Artemis Moon Rocket’s engines generate
0 Comments
  THE GLOBAL FILM ALLIANCE The G.F.A. in Hollywood with a Powerful Collaboration of International Film Production Companies. Eleven independent film companies- JJ Filmworks and A Plus Films from Bulgaria,Talkinglens Productions from the UK, Montalvo Digital Studios, UK, Hollywood Entertainment News, USA, Night Owl Studio, California USA, Wartime Films, USA, 360 Studios LTD, USA, 360TVN,
0 Comments
Recreational drug use has been prevalent in societies for centuries, and it continues to be a topic of interest and concern. As the pursuit of altered states of consciousness persists, it becomes crucial to prioritize the safety and well-being of individuals engaging in such activities. One effective strategy in harm reduction is the testing of
0 Comments
In this article LLY NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News medical contributor, believes fresh data from Novo Nordisk on Ozempic’s ability to delay the progression of chronic kidney disease is among the strongest supporting
0 Comments